University of Copenhagen
Evosep Launches High-Throughput Proteomics Platform Eno and Expands SCIEX Partnership at ASMS 2025
Evosep unveiled the Evosep Eno, a high-throughput separation platform that can analyze over 500 samples per day and identify close to 7,000 proteins with 40% improved performance.
Ousia Pharma Secures Seed Financing from Omega Funds to Develop Novel Obesity Treatment Targeting NMDA Receptors
Ousia Pharma has secured significant seed financing from Omega Funds to advance its dual-incretin-NMDA receptor antagonist conjugate for obesity treatment through preclinical and early clinical development.
Glofitamab Plus Polatuzumab Demonstrates Durable Responses in Relapsed/Refractory LBCL
Glofitamab combined with polatuzumab vedotin shows high response rates and durable remissions in heavily pretreated relapsed/refractory large B-cell lymphoma (LBCL).
Vitamin B3 Shows Promise in Reducing Lung Inflammation in COPD Patients
A recent study reveals that daily intake of vitamin B3 significantly reduces lung inflammation in individuals with Chronic Obstructive Pulmonary Disease (COPD).
NK2R Agonist Shows Promise for Weight Loss Without Muscle Loss in Preclinical Study
A novel drug candidate, NK2R, has demonstrated weight loss effects in preclinical studies by targeting appetite and increasing calorie burning.